The clinical evolution of DBA patients is unpredictable, and complications are usually severe, most of which are associated with treatment due to the chronic use of corticosteroids, increased iron levels, infections, and side effects associated with transplantation. 16, 18 In addition, DBA patients are at higher risk of acquiring malignant diseases, solid tumors (bone, breast, and digestive tract cancers), and hematological neoplasias. 1, 16 Neutropenia is characterized by low total neutrophil counts. In peripheral blood, normal neutrophil counts stand between 3,000 and 6,000 cells/mm 3 , and values below 500 cells/mm 3 indicate severe neutropenia. [26] [27] [28] The occurrence of oral lesions in DBA has been correlated with the severity of neutropenia and thrombocytopenia. 26 Fever of unknown origin may be reported, and oral manifestations usually start with the emergence of petechiae that, in more severe cases, evolve to gingivitis, necrotic lesions in the palate and gingivae, stomatitis, cellulitis, abscesses, and other severe systemic infections. 17, 26, 28, 29 Since the inflammatory response in patients with neutropenia is less intense, signs of infection such as thermal discomfort, blushing, and edema are less evident or may not even be present at all. After agranulocytosis that may stretch from a few days to a few weeks, patients report fever, fits of cold shivering, general indisposition, and considerable weariness in some cases. Pulmonary and oropharyngeal infection foci are also observed., Additionally, urinary tract infections and other signs are also reported. 27, 28 This study presents a case of DBA in a patient with oral mucosa lesions due to secondary neutropenia who underwent treatment in the Stomatology Unit, Hospital de Clínicas de Porto team as a tool towards diagnosis and treatment of the oral lesions.
The patient's clinical history included severe hyporesponsive anemia since childhood, splenectomy at the age of 10 years, DBA diagnosis confirmed at the age of 17 years after bone marrow biopsy, and Cushing Syndrome due to chronic use of corticosteroids. Physical examination did not reveal any change associated with DBA as described in the literature, The initial diagnostic hypothesis was of ulcers associated with neutropenia, more severe by secondary contamination and reduced inflammatory response. Diagnosis was made clinically, with no need for biopsy or histopathological investigation, at that time.
During the 18 days the patient was hospitalized, the urinary infection was treated with intravenous antibiotics (cefepime 2 g every 8 h for 5 days, vancomycin 1.5 g every 12 h for 7 days) and oral antibiotics (sulfamethoxazole and trimethoprim 960 mg every 12 h for 14 days). Severe and persistent anemia with neutropenia was treated with blood transfusions and granulocyte colony-stimulating factor (G-CSF, filgrastim) upon hemodynamic stabilization.
This treatment was defined by the medical team.
The stomatological treatment was carried out using three approaches: a) daily low-frequency laser therapy to reduce pain and stimulate cellular renovation and lesion healing, b) chlorhexidine 0.12% mouthwashes twice a day to chemically control biofilm formation and therefore avoid secondary contamination of oral ulcers, which would delay healing, and c) topic lidocaine 10% spray (to make eating more comfortable). The patient was examined daily by the stomatology team as a means to monitor the healing of oral lesions, which was If total reparation of oral lesions had not been observed, then partial biopsy of one ulcer would have been prescribed. In this case, differential diagnosis would be reached based on infectious diseases and autoimmune mucocutaneous diseases that may elicit multiple oral mucosa lesions. These diseases would include syphilis, deep mycoses, lichen planus, pemphigus, and pemphigoids.
Currently the patient is being followed up clinically, polytransfused, and receiving concentrated adult erythrocyte suspensions once a week. Iron overdose is also being controlled. Hemoglobin and erythrocyte counts remain extremely low despite treatment with erythropoietin, prednisone, and cyclosporine A. However, no new neutropenia has emerged, and no other oral lesions have been observed.
Discussion
DBA was first described by Josephs in 1936. 30 The disease often manifests between the third month and the second year of life, 16 though it has been diagnosed in patients from other age groups. 15 Recent data show that approximately 40% to 50% of DBA cases are inherited in an autosomal dominant pattern, 4, 20, 31 though gene transmission is unpredictable. 17 The hereditary character of the disease underlines the importance of a genetic counseling. 4, 32 Prevalence of DBA is at one case in every 100,000 to 200,000 inhabitants, with no ethnic or gender predisposition. 1, 5, 8, 19, 21 Few studies have investigated the diagnosis of DBA in adult patients. 33 In the present case report, the patient did not present the physical anomalies associated with DBA, which make early diagnosis more difficult. Although the patient exhibited severe anemia since the very first months of life, a conclusive diagnosis was not reached until she was 17-years-old. Another critical issue lies in the fact that the patient was born and lived in a small town in the state of Rio Grande do Sul, Brazil, where specialized health services are not available to diagnose rare hematological diseases. DBA has traditionally been described as a pure red cell aplasia (PRCA), with defects restricted to the erythroid linage, 9 though the first reports described mild neutropenia and thrombocytopenia. A case series study that analyzed the evolution of DBA in 28 patients
pointed to a statistically significant number of individuals who were unresponsive to corticosteroid therapy, and who developed thrombocytopenia and/or neutropenia with increasing age. 9 Eleven patients were followed up for more than 15 years, of which six presented with some degree of cytopenia, and one died from neutropenic sepsis. 9 Seventyfive percent of patients exhibited lower counts of the three blood cell lines. Four individuals presented neutropenia, of which three also manifested thrombocytopenia.
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Agranulocytosis may also be induced by medicinal drugs, culminating in a relevant and sudden hematological condition that emerges as a result of an idiosyncratic reaction to a given medicament. The mechanism behind neutropenia has not been completely elucidated, though the condition has been reported to occur due to the prolonged treatment with a specific medicinal drug, metabolic conditions, lowered neutrophil production in the bone marrow, or high plasma levels of a drug. 27 In the present report, the patient manifested severe febrile neutropenia at the age of 19 years, requiring admission to a hospital to treat opportunistic infections and ensure hemodynamic stabilization. Among the co-morbidities associated with febrile neutropenia, the literature cites urinary tract infections and aggressive, painful ulcers on the oral cavity that are
Stomatological expression of Diamond-Blackfan Anemia Page 9 Copyright © 2016 Marshfield Clinic Health System morphologically similar to those described in cyclic neutropenia patients. 17 Apart from presenting with DBA, the patient was given prednisone, cyclosporine A, deferasirox, and erythropoietine chronically. It should be emphasized that the literature reports the death of a 12-year-old girl from agranulocytosis induced by deferiprone, a chelating agent. 20, 23 However, although deferasirox is a chelating agent also, it is efficient and safe for controlling iron levels 24, 34, 35, 36 and has been linked to agranulocytosis only when administered at high doses. 16 Patients with febrile neutropenia require long-term, broad-spectrum antibiotic therapy, depending on the associated etiologic agent. [27] [28] [29] Severe cases demand hospital admission with isolation of the patient and strict antiseptic measures, apart from specific care in terms of diet and oral health. 27 In the present case report, the patient exhibited severe neutropenia, urinary infection, and painful crateriform lesions on the oral mucosa. In such a scenario, the patient was admitted to hospital to receive the appropriate intravenous antibiotic regimen to eliminate the infection in the urinary tract. Moreover, the period of hospitalization also allowed for administration of filgastrim to quickly increase neutrophil counts and to conduct blood transfusions until hemodynamic balance was reached. 27 Since the oral lesions would have healed spontaneously with recovery of the hematological condition, our approach was directed to palliative care. The mouth was rinsed with aqueous chlorhexidine 0.12% solution every 12 h to prevent any secondary infection of the lesions. Also, lidocaine 10% topic spray applications were prescribed to mitigate symptoms, and daily laser therapy sessions were prescribed as adjuvant analgesic therapy and to speed up healing.
The specific approaches prescribed to increase absolute neutrophil counts include corticosteroid therapies as well as the prescription of intravenous immunoglobulins and
Stomatological expression of Diamond-Blackfan Anemia Page 10 Copyright © 2016 Marshfield Clinic Health System plasmapheresis, especially for patients with severe infectious complications. 27 Myeloid lineage growth factors such as G-CSF (filgastrim/lenograstim) and GM-CSF (molgramostim) stimulate the production of neutrophil precursor cells and activate the phagocytic and cytotoxic functions of mature neutrophils. Among the beneficial effects of G-CSF are increased neutrophil counts, shorter neutropenia times, and lower infection rates, apart from the possibility of reducing hospital admissions. 28, 37 Filgastrim induces a fast increase in circulating neutrophil counts, eliciting the remission of oral lesions caused by neutropenia.
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A case report of two patients with DBA 13 described the issues affecting oral health status in this disease. Although a considerable build-up of biofilm was reported due to poor oral hygiene, the other periodontal conditions of these patients were considered normal. Few studies have described oral findings in DBA patients. The oral and dental conditions reported include severe gingivitis, multiple caries lesions, impacted third molars, and obliteration of the crown pulp chamber. 13 In the present case report, the patient presented with good mechanical control of biofilm formation, with preserved teeth and no evidence of periodontal disease. Currently she is under orthodontic treatment.
Corticosteroid regimens, chronic blood transfusions, and HSCT are the current treatments of choice for DBA. 3, 23 According to the USA DBA databank, overall survival is 75.1% at the age of 40, which requires concerted efforts in the search for new alternatives for increasing survival rates at the same time that any complications associated with these therapies are mitigated. 3, 18, 23 HSCT is prescribed when the patient requires constant blood transfusiony, and it is the only definitive treatment for hematological manifestations of DBA. Guidelines, which established the diagnosis and treatment criteria for DBA that are currently adopted, recommends that HSCT be prescribed as the treatment of choice for patients of up to 10-years-of-age. For older patients, it is recommended only to treat cytopenia that affects lineages other than the erythroid, myelodysplasia, and acute myeloid leukemia. 23 Promising results have been described for bone marrow transplants from consanguineous donors, though an in-depth evaluation of possibilities is required in light of the risk of DBA in the family and the complex diagnosis of the condition. 1, 7, 8, 16, 22 Evaluation of the patient by the medical team indicated that transplantation was not appropriate at that moment. The literature indicates that HSCT should be carried out only if remission after other therapies is not observed. 6, 14, 22 However, the remission mechanism of DBA remains unclear. 6 A previous study concluded that HSCT conducted before multiple transfusions reduces iron levels, improving neutrophil and platelet recovery after transplantation.
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Conclusion
Descriptions of oral manifestations associated with DBA in the literature are rare. Based on this case report and on the literature review, it is possible to conclude that the oral ulcers observed had no direct association with DBA, but with neutropenia, which is a frequent comorbidity factor in these patients.
The role of a stomatologist in the transdisciplinary team treating patients with DBA is justified in light of the importance of accompanying oral health conditions, in addition to the diagnosis and treatment of oral lesions. Whenever necessary, a patient with DBA may be referred for conventional less invasive dental treatment in specific oral health units.
Oral lesions in patients with DBA may be associated with hemodynamic imbalance, which
